Bysanti

Bysanti · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Mar 28, 2028

~1.7 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (63)

May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4434)US 12478619
May 31, 2044method-of-use (U-4435)US 12478619
Dec 28, 2031method-of-use (U-4436)US 9074254
Dec 28, 2031method-of-use (U-4437)US 9074254
Dec 28, 2031method-of-use (U-4436)US 9074254
Dec 28, 2031method-of-use (U-4436)US 9074254
Dec 28, 2031method-of-use (U-4436)US 9074254
Dec 28, 2031method-of-use (U-4436)US 9074254
Dec 28, 2031method-of-use (U-4436)US 9074254
Feb 10, 2031method-of-use (U-4436)US 90742564.6y
Feb 10, 2031method-of-use (U-4436)US 90742564.6y
Feb 10, 2031method-of-use (U-4436)US 90742564.6y
Feb 10, 2031method-of-use (U-4437)US 90742564.6y
Feb 10, 2031method-of-use (U-4437)US 90742564.6y
Feb 10, 2031method-of-use (U-4437)US 90742564.6y
Feb 10, 2031method-of-use (U-4437)US 90742564.6y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Jan 16, 2031method-of-use (U-4437)US 90727424.5y
Dec 17, 2030method-of-use (U-4437)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Dec 17, 2030method-of-use (U-4436)US 90742554.4y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Oct 28, 2030method-of-use (U-4437)US 89996384.3y
Jul 24, 2030method-of-use (U-4437)US 105632594.0y
Jul 24, 2030method-of-use (U-4437)US 105632594.0y
Jul 24, 2030method-of-use (U-4436)US 105632594.0y
Jul 24, 2030method-of-use (U-4436)US 105632594.0y
Jul 24, 2030method-of-use (U-4437)US 105632594.0y
Jul 24, 2030method-of-use (U-4437)US 105632594.0y
Jul 24, 2030method-of-use (U-4437)US 105632594.0y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Apr 5, 2030method-of-use (U-4437)US 91571213.7y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Apr 5, 2030method-of-use (U-4436)US 91571213.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y
Mar 28, 2028method-of-use (U-4437)US 105704531.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y
Mar 28, 2028method-of-use (U-4436)US 105704531.7y

milsaperidone

indications

all catalysts(0)

News(0)

Patent cliff

patents (63)

Report a data issue

comments(0)

🐶 often sniffed alongside

Trials studying milsaperidone